Tuberculosis in liver transplant recipients: A single brazilian center experience

Transplantation

Volumn 87, Issue 3, 2009, Pages 397-401

  Clemente, Wanessa T ^a   Faria, Luciana C ^a   Lima, Stella S S ^a   Vilela, Eduardo G ^a   Lima, Agnaldo S ^a   Velloso, Luiz F ^a   Sanches, Marcelo D ^a   Cançado, Omar L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antituberculosis therapy; Liver transplant recipients; Tuberculosis

Indexed keywords

BASILIXIMAB; CARBAMAZEPINE; CORTICOSTEROID; CYCLOSPORIN A; ETHAMBUTOL; ISONIAZID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BRAZIL; CHEMOPROPHYLAXIS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GRAFT REJECTION; HEALTH CENTER; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MILIARY TUBERCULOSIS; PRIORITY JOURNAL; RECURRENT INFECTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; DISEASE TRANSMISSION; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDY; SKIN TEST; STATISTICS; UNIVERSITY HOSPITAL;

ADULT; ANTITUBERCULAR AGENTS; BRAZIL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TESTS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 61849101006     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819289d0     Document Type: Article

References (16)

1. Muñoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581.
2. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solidorgan transplant recipients: Impact and implications for management. Clin Infect Dis 1998; 27: 1266.
3. Muñoz P, Palomo J, Muñoz R, et al. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21: 398.
4. Garcia-Leoni ME, Martin-Scapa C, Rodeño P, et al. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990; 9: 283.
5. Ruffino Netto A. Programa de Controle da Tuberculose no Brasil: Situação atuale novas perspectivas. Inf Epidemiol SUS set 2001; 10: 129.
6. Aguado JM, Herrero JA, Gavaldá J, et al.; the Spanish Transplantation Infection Study Group, GESITRA. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation 1997; 63: 1278.
7. Chugh KS, Jha V. Tuberculosis in organ transplant recipients. Transplantation Proc 2003; 35: 2676.
8. Meyers BR, Halpern M, SheinerP,et al. Tuberculosisin liver transplant recipients. Transplantation 1994; 58: 301.
9. Torre-Cisneros J, de la Mata M, Rufian S, et al. Importance of surveillance mycobacterial cultures after liver transplantation. Transplantation 1995; 60: 1054.
10. Meyers BR, Papanicolaou GA, Sheiner P, et al. Tuberculosis in ortho-topic liver transplant patients: Increased toxicity of recommended agents; cureofdisseminated infection with nonconventional regimens. Transplantation 2000; 69: 64.
11. Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002; 74: 1381.
12. Nishizaki T, Yanaga K, Soejima Y, et al. Tuberculosis following liver transplantation: Report of a case and review of the literature. Transpl Int 1996; 9: 589.
13. SinnottJTIV, Emmanuel PJ. Mycobacterial infectionsin the transplant patient. Semin Respir Infect 1990; 5: 65.
14. Oh C-S, Stratta RJ, Fox BC, et al. Increased infections associated with the use of OKT3 for treatment of steroid resistant rejection in renal transplantation. Transplantation 1990; 45: 68.
15. Reported tuberculosis in the United States, 1999. Atlanta, Centers for Disease Control and Prevention 2000.
16. Schluger LK, Sheiner PA, Jonas M, et al. Isoniazid hepatotoxicity after orthotopic liver transplantation. Mt Sinai J Med 1996; 63: 364.